Shared-Care in Complex Malignant Hematology: An Integrative Review Using the RE-AIM Evaluation Framework von Nixon, Shannon M, Maze, Dawn C, Parry, Monica, Mayo, Samantha J

Volltext

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute... von Murphy, Tracy, Zou, Jinfeng, Arruda, Andrea, Wang, Ting Ting, Zhao, Zhen, Zheng, Yangqiao, Gupta, Vikas, Maze, Dawn, McNamara, Caroline, Minden, Mark D, Schimmer, Aaron, Sibai, Hassan, Yee, Karen, Capo-Chichi, Jose-Mario, Stockley, Tracy, Schuh, Andre, Bratman, Scott V, Chan, Steven M

Volltext

Osteolytic lesion in polycythemia vera: First report and review of literature von Cheung, Verna, England, James, Maze, Dawn, Sibai, Hassan

Volltext

Genomic profiles and outcomes in de novo versus therapy-related core binding factor AML von Chiu, May, Schimmer, Aaron D., Schuh, Andre C., Bankar, Aniket, Richard-Carpentier, Guillaume, Sibai, Hassan, Yee, Karen, Davidson, Marta, Chan, Steven M., Gupta, Vikas, Maze, Dawn

Volltext

Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase von Perusini, Maria Agustina, Andrews, Claire, Atenafu, Eshetu G, Gupta, Vikas, Maze, Dawn, Schuh, Andre C, Yee, Karen Wl, Bankar, Aniket, Davidson, Marta B, Richard-Carpentier, Guillaume, Chan, Steven M, Sibai, Jad, Schimmer, Aaron D, Minden, Mark D, Sibai, Hassan

Volltext

Biallelic disruption of DDX41 activity is associated with distinct genomic and immunophenotypic hallmarks in acute leukemia von Tierens, Anne, Kagotho, Elizabeth, Shinriki, Satoru, Seto, Andrew, Smith, Adam C, Care, Melanie, Maze, Dawn, Sibai, Hassan, Yee, Karen W, Schuh, Andre C, Kim, Dennis Dong Hwan, Gupta, Vikas, Minden, Mark D, Matsui, Hirotaka, Capo-Chichi, José-Mario

Volltext

Measurable residual disease monitoring provides insufficient lead-time to prevent morphologic relapse in the majority of patients with core-binding factor acute myeloid leukemia von Puckrin, Robert, Atenafu, Eshetu G, Claudio, Jaime O, Chan, Steven, Gupta, Vikas, Maze, Dawn, McNamara, Caroline, Murphy, Tracy, Shuh, Andre C, Yee, Karen, Sibai, Hassan, Minden, Mark D, Wei, Cuihong, Stockley, Tracy, Kamel-Reid, Suzanne, Schimmer, Aaron D

Volltext

Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms von Maze, Dawn, Arusi, Iyad, Gupta, Vikas, Atenafu, Eshetu G., Malinowski, Ann Kinga, Shehata, Nadine

Volltext

P1040: FACTORS ASSOCIATED WITH THROMBOSIS IN MYELOFIBROSIS von Bankar, Aniket, Gupta, Gopila, Cheung, Verna, Claudio, Jaime O., Arruda, Andrea, Tsui, Hubert, Capo‐Chichi, Jose‐Mario, Sibai, Hassan, Davidson, Marta, Maze, Dawn, Gupta, Vikas

Volltext

P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE von Agustina Perusini, Maria, Gupta, Vikas, Bankar, Aniket, Sibai, Jad, Minden, Mark, Maze, Dawn, Davidson, Marta, Richard‐Carpentier, Guillaume, M Chan, Steven, Schuh, Andre, Yee, Karen, Atenafu, Eshetu, Sibai, Hassan

Volltext

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy von Spiegel, Jay Y., McNamara, Caroline, Kennedy, James A., Panzarella, Tony, Arruda, Andrea, Stockley, Tracy, Sukhai, Mahadeo, Thomas, Mariam, Bartoszko, Justyna, Ho, Jenny, Siddiq, Nancy, Maze, Dawn, Schimmer, Aaron, Schuh, Andre, Sibai, Hassan, Yee, Karen, Claudio, Jamie, Devlin, Rebecca, Minden, Mark D., Kamel-Reid, Suzanne, Gupta, Vikas

Volltext

The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes von McNamara, Caroline J., Panzarella, Tony, Kennedy, James A., Arruda, Andrea, Claudio, Jaime O., Daher-Reyes, Georgina, Ho, Jenny, Siddiq, Nancy, Devlin, Rebecca, Tsui, Hubert, Su, Jie, Stockley, Tracy, Sukhai, Mahadeo, Kanwar, Nisha, Chan, Steven, Maze, Dawn, Schimmer, Aaron, Schuh, Andre, Sibai, Hassan, Viswabandya, Auro, Yee, Karen, Minden, Mark D., Kamel-Reid, Suzanne, Gupta, Vikas

Volltext

Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen von Al Nabhani, Ibrahim, Andrews, Claire, Sibai, Jad, Atenafu, Eshetu, Young, Taylor, Chan, Steven M., Gupta, Vikas, Maze, Dawn, Schimmer, Aaron D., Schuh, Andre C., Yee, Karen, Sibai, Hassan

Volltext

Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen von Chen, Ruiqi, Liu, Xing, Law, Arjun D., Kanfar, Solaf, Maze, Dawn, Chan, Steven M., Gupta, Vikas, Yee, Karen W., Minden, Mark D., Schimmer, Aaron D., Schuh, Andre C., McNamara, Caroline J., Murphy, Tracy, Xu, Anna, Falcone, Umberto, Seki, Jack, Sibai, Hassan

Volltext

Clinical Utility of Next‐generation Sequencing in the Management of Myeloproliferative Neoplasms: A Single‐Center Experience von Alduaij, Waleed, McNamara, Caroline J., Schuh, Andre, Arruda, Andrea, Sukhai, Mahadeo, Kanwar, Nisha, Thomas, Mariam, Spiegel, Jay, Kennedy, James A., Stockley, Tracy, Tsui, Hubert, Devlin, Rebecca, Sibai, Hassan, Maze, Dawn, Schimmer, Aaron, Yee, Karen, Chan, Steven, Kamel‐Reid, Suzanne, Gupta, Vikas

Volltext

A case of secondary acute myeloid leukemia on a background of glycogen storage disease with chronic neutropenia treated with granulocyte colony stimulating factor von Khalaf, Dina, Bell, Heather, Dale, David, Gupta, Vikas, Faghfoury, Hanna, Morel, Chantal F., Tierens, Anne, Weinstein, David A., Yan, Jiong, Thyagu, Santhosh, Maze, Dawn

Volltext

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML von Murphy, Tracy, Zou, Jinfeng, Daher-Reyes, Georgina S., Arruda, Andrea, Gupta, Vikas, McNamara, Caroline J., Minden, Mark D., Schimmer, Aaron D., Sibai, Hassan, Yee, Karen W.L., Korulla, Mariam, Stockley, Tracy, Kamel-Reid, Suzanne, Maze, Dawn, Tierens, Anne, Bratman, Scott V., Schuh, Andre C., Chan, Steven M.

Volltext

Combination treatment with CPX‐351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature von Andrews, Claire, Maze, Dawn, Murphy, Tracy, Sibai, Hassan

Volltext

Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference von Mueller, Markus M, Van Remoortel, Hans, Meybohm, Patrick, Aranko, Kari, Aubron, Cécile, Burger, Reinhard, Carson, Jeffrey L, Cichutek, Klaus, De Buck, Emmy, Devine, Dana, Fergusson, Dean, Folléa, Gilles, French, Craig, Frey, Kathrine P, Gammon, Richard, Levy, Jerrold H, Murphy, Michael F, Ozier, Yves, Pavenski, Katerina, So-Osman, Cynthia, Tiberghien, Pierre, Volmink, Jimmy, Waters, Jonathan H, Wood, Erica M, Seifried, Erhard

Volltext

Safety and Efficacy of JAK Inhibitor Therapy in BCR-ABL Negative MPN Patients with Underlying Portal Hypertension von Davidson, Marta, Smith, Elliot, Maze, Dawn, Sibai, Hassan, Gupta, Vikas, Cheung, Verna, Nye, Taylor

Volltext